ネクセラファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/11/01 | 1,410 | 1,410 | 1,371 | 1,398 | +8 | +0.6% | 1,084,000 |
| 2023/10/31 | 1,341 | 1,395 | 1,339 | 1,390 | +54 | +4% | 846,300 |
| 2023/10/30 | 1,360 | 1,377 | 1,332 | 1,336 | -40 | -2.9% | 851,300 |
| 2023/10/27 | 1,328 | 1,376 | 1,308 | 1,376 | +36 | +2.7% | 995,400 |
| 2023/10/26 | 1,336 | 1,364 | 1,332 | 1,340 | -12 | -0.9% | 832,200 |
| 2023/10/25 | 1,379 | 1,383 | 1,349 | 1,352 | +3 | +0.2% | 548,800 |
| 2023/10/24 | 1,325 | 1,350 | 1,296 | 1,349 | +25 | +1.9% | 1,222,700 |
| 2023/10/23 | 1,344 | 1,358 | 1,310 | 1,324 | -20 | -1.5% | 928,400 |
| 2023/10/20 | 1,350 | 1,354 | 1,313 | 1,344 | -23 | -1.7% | 1,299,200 |
| 2023/10/19 | 1,386 | 1,400 | 1,367 | 1,367 | -41 | -2.9% | 976,500 |
| 2023/10/18 | 1,405 | 1,409 | 1,385 | 1,408 | +6 | +0.4% | 932,800 |
| 2023/10/17 | 1,409 | 1,421 | 1,375 | 1,402 | +11 | +0.8% | 1,050,100 |
| 2023/10/16 | 1,436 | 1,437 | 1,380 | 1,391 | -56 | -3.9% | 1,299,700 |
| 2023/10/13 | 1,467 | 1,470 | 1,442 | 1,447 | -31 | -2.1% | 701,400 |
| 2023/10/12 | 1,445 | 1,508 | 1,439 | 1,478 | +36 | +2.5% | 909,600 |
| 2023/10/11 | 1,432 | 1,444 | 1,422 | 1,442 | +5 | +0.3% | 752,700 |
| 2023/10/10 | 1,435 | 1,452 | 1,429 | 1,437 | +8 | +0.6% | 487,300 |
| 2023/10/06 | 1,450 | 1,456 | 1,421 | 1,429 | -12 | -0.8% | 614,000 |
| 2023/10/05 | 1,427 | 1,443 | 1,391 | 1,441 | +31 | +2.2% | 1,262,500 |
| 2023/10/04 | 1,412 | 1,434 | 1,403 | 1,410 | -24 | -1.7% | 1,319,200 |
| 2023/10/03 | 1,449 | 1,468 | 1,432 | 1,434 | -34 | -2.3% | 1,045,600 |
| 2023/10/02 | 1,500 | 1,507 | 1,465 | 1,468 | -24 | -1.6% | 893,600 |
| 2023/09/29 | 1,521 | 1,523 | 1,483 | 1,492 | -31 | -2% | 1,047,300 |
| 2023/09/28 | 1,538 | 1,544 | 1,515 | 1,523 | -23 | -1.5% | 570,900 |
| 2023/09/27 | 1,515 | 1,560 | 1,512 | 1,546 | +31 | +2% | 713,000 |
| 2023/09/26 | 1,529 | 1,538 | 1,510 | 1,515 | -22 | -1.4% | 812,400 |
| 2023/09/25 | 1,538 | 1,547 | 1,517 | 1,537 | -10 | -0.6% | 912,500 |
| 2023/09/22 | 1,541 | 1,577 | 1,534 | 1,547 | -20 | -1.3% | 898,100 |
| 2023/09/21 | 1,608 | 1,610 | 1,560 | 1,567 | -56 | -3.5% | 996,900 |
| 2023/09/20 | 1,601 | 1,633 | 1,592 | 1,623 | +17 | +1.1% | 805,400 |
| 2023/09/19 | 1,600 | 1,646 | 1,596 | 1,606 | +18 | +1.1% | 1,380,200 |
| 2023/09/15 | 1,572 | 1,616 | 1,562 | 1,588 | +23 | +1.5% | 4,525,100 |
| 2023/09/14 | 1,594 | 1,595 | 1,551 | 1,565 | -40 | -2.5% | 2,263,900 |
| 2023/09/13 | 1,631 | 1,637 | 1,575 | 1,605 | -22 | -1.4% | 1,887,200 |
| 2023/09/12 | 1,646 | 1,679 | 1,626 | 1,627 | +2 | +0.1% | 1,345,000 |
| 2023/09/11 | 1,639 | 1,647 | 1,614 | 1,625 | -13 | -0.8% | 683,400 |
| 2023/09/08 | 1,648 | 1,671 | 1,633 | 1,638 | -14 | -0.8% | 902,100 |
| 2023/09/07 | 1,648 | 1,664 | 1,641 | 1,652 | -5 | -0.3% | 740,400 |
| 2023/09/06 | 1,693 | 1,703 | 1,657 | 1,657 | -23 | -1.4% | 904,100 |
| 2023/09/05 | 1,651 | 1,683 | 1,651 | 1,680 | +17 | +1% | 719,100 |
| 2023/09/04 | 1,657 | 1,683 | 1,651 | 1,663 | +5 | +0.3% | 924,400 |
| 2023/09/01 | 1,658 | 1,663 | 1,629 | 1,658 | -2 | -0.1% | 1,033,500 |
| 2023/08/31 | 1,694 | 1,708 | 1,658 | 1,660 | -39 | -2.3% | 1,445,700 |
| 2023/08/30 | 1,718 | 1,727 | 1,690 | 1,699 | -16 | -0.9% | 981,000 |
| 2023/08/29 | 1,682 | 1,728 | 1,678 | 1,715 | +68 | +4.1% | 1,725,700 |
| 2023/08/28 | 1,643 | 1,678 | 1,637 | 1,647 | +10 | +0.6% | 991,100 |
| 2023/08/25 | 1,661 | 1,664 | 1,628 | 1,637 | -42 | -2.5% | 1,167,700 |
| 2023/08/24 | 1,706 | 1,712 | 1,674 | 1,679 | +3 | +0.2% | 759,100 |
| 2023/08/23 | 1,691 | 1,706 | 1,675 | 1,676 | -31 | -1.8% | 960,000 |
| 2023/08/22 | 1,676 | 1,729 | 1,670 | 1,707 | +31 | +1.8% | 1,209,700 |
351～
400
件表示中 / 5067件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ネクセラファーマ | 75,200円 | +22.8% | - | 0.00% | 61.44倍 | 0.99倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 栄研化 | 214,500円 | +0.4% | -8.4% | 2.47% | 27.54倍 | 1.56倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| クオリプス | 862,000円 | +660.9% | - | 0.00% | - | 12.51倍 |
|
大阪大学発ベンチャー。ｉＰＳ細胞由来のシートによる世界初の重症心不全治療法開発に注力 |
| あすかＨＤ | 227,400円 | +0.3% | +2.7% | 2.20% | 12.90倍 | 1.00倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
| ＪＣＲファーマ | 42,600円 | -23.0% | - | 4.69% | - | 0.92倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
市場注目の銘柄
チャート関連のコラム
